Form 4: Hims & Hers CMO Executes RSU Conversions

Chief Medical Officer Patrick Harrison Carroll acquired 4,091 shares of Hims & Hers Health, Inc. through the vesting of restricted stock units.

Summary

• Chief Medical Officer Patrick Harrison Carroll acquired a total of 4,091 shares of Class A Common Stock.
• 3,656 shares were acquired on June 11, 2026, via the vesting of Restricted Stock Units (RSUs).
• 435 shares were acquired on June 15, 2026, representing the conversion of RSUs issued in lieu of Q1 2026 director retainer fees.
• Following these transactions, the reporting person holds 187,971 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it reflects standard executive compensation and equity vesting rather than a discretionary market move.

Positives

• Increased equity ownership by a key executive, aligning interests with shareholders.

Negatives

• None identified; this is a standard equity compensation settlement.

Risks

• Standard market risks associated with equity holdings in the healthcare technology sector.

Future Outlook

No forward-looking guidance provided in this filing.

Management Comments

• None provided.

Industry Context

StockSavvy.ai notes that executive equity acquisitions via RSU vesting are routine corporate governance events and do not typically signal a change in strategic direction or market outlook.

Comparison to Industry Standards

• The use of RSUs in lieu of cash retainer fees is a common practice among growth-stage healthcare companies to preserve cash flow.

Stakeholder Impact

• Minimal impact on shareholders as these are standard equity compensation settlements.

Next Steps

• None mentioned.

Key Dates

Keywords

HIMS, Hims & Hers Health, Form 4, Insider Trading, Equity Compensation, Restricted Stock Units